Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Colchicine in Chronic Limb-Threatening Ischemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates a study of colchicine for chronic limb-threatening ischemia and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital | Conditions: Chronic Limb-Threatening Ischemia | Phase 3 | Status: NOT_YET_RECRUITING